Long term outcomes from catheter ablation of very longstanding persistent atrial fibrillation

Karen P Phillips1, Daniel T Walker1

  • 1HeartCare Partners, GenesisCare, Greenslopes Private Hospital, Newdegate St, Greenslopes, Brisbane, QLD 4120, Australia.

Insights

Catheter ablation for very longstanding persistent atrial fibrillation (AF) in 29 patients resulted in 83% maintaining sinus rhythm long-term. However, most required additional treatments like antiarrhythmics or repeat procedures.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Catheter ablation success rates for longstanding persistent atrial fibrillation (AF) are lower than for paroxysmal or recent-onset forms.
  • This study investigates long-term outcomes of catheter ablation for very longstanding persistent AF (duration > 2 years).

Purpose of the Study:

  • To evaluate the long-term efficacy and outcomes of catheter ablation in patients with symptomatic very longstanding persistent AF.
  • To assess the need for adjunctive therapies and repeat procedures in this patient cohort.

Main Methods:

  • Retrospective analysis of 29 patients with symptomatic very longstanding persistent AF undergoing catheter ablation between 2008 and 2013.
  • Follow-up duration averaged 61 months post-ablation.
  • Procedures included antral pulmonary vein isolation, with some patients receiving additional lines and/or CFAE ablation.

Main Results:

  • 83% of patients maintained sinus rhythm at long-term follow-up (mean 61 months).
  • Only 31% remained free of detectable arrhythmia; 86% required antiarrhythmic therapy, and 62% needed DC cardioversions.
  • The mean time to first AF recurrence was 14 months, with 45% undergoing redo ablation.
  • Significant improvement in symptom scores (EHRA) was observed (p<0.0001).

Conclusions:

  • Catheter ablation can maintain sinus rhythm in a majority of very longstanding persistent AF patients long-term.
  • Adjunctive therapies, including antiarrhythmics, DC cardioversions, and repeat ablations, are frequently necessary.
  • Despite the need for further interventions, ablation significantly improves symptom burden in this challenging patient group.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
566
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
603
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
977